Objectives: 

1. To discuss current immunosuppression in kidney transplantation (including mTOR inhibitors)
2. To assess the impact of TORKinibs on APC ,T cell and B cell function in vitro and in vivo
3. To assess the impact of TORKinibs on acute cellular rejection
4. To assess the impact of TORKinibs on alloantibody production
5. To compare and contrast these immunologic effects with Rapamycin
Session date: 
Wednesday, February 15, 2017 - 4:00pm to 5:00pm
Speaker Name: 
Dr. Daniel Fantus
Location: 
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.